APD
32
3
KLAC
65
6
MHK
42
-6
TSCO
66
11
VLO
33
-2
CTAS
55
2
WDC
58
3
WU
48
6
CINF
41
-9
KMI
46
-2
XYL
60
4
PX
15
2
MPC
52
10
AVB
62
-2
OKE
71
-3
DTE
40
-2
JNJ
26
2
PRGO
66
9
HBI
20
2
FCX
56
2
APD
32
3
KLAC
65
6
MHK
42
-6
TSCO
66
11
VLO
33
-2
CTAS
55
2
WDC
58
3
WU
48
6
CINF
41
-9
KMI
46
-2
XYL
60
4
PX
15
2
MPC
52
10
AVB
62
-2
OKE
71
-3
DTE
40
-2
JNJ
26
2
PRGO
66
9
HBI
20
2
FCX
56
2
Financhill
Back

Dr Reddy's Laboratories 10K Form

Sell
45

RDY
Dr Reddy's Laboratories

Last Price:
74.84
Seasonality Move:
2.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RDY News And Ratings

See the #1 stock for the next 7 days that we like better than RDY

RDY Financial Statistics

Sales & Book Value

Annual Sales: $3.07B
Cash Flow: $-4.76M
Price / Cash Flow: 34.59
Annual Sales: $19.27
Price / Book: 3.87

Profitability

EPS (TTM): 3.79400
Net Income (TTM): $632.08M
Gross Margin: $1.74B
Return on Equity: 21.48%
Return on Assets: 15.51%

Dr Reddy's Laboratories Earnings Forecast

Key Dr Reddy's Laboratories Financial Ratios

  • The Gross Profit Margin over the past 23 years for RDY is 56.67%.
  • The Selling, General & Administrative Expenses for RDY have been equal to 27.67% of Gross Profit Margin.
  • The Research & Development expenses have been 7.88% of Revenue.
  • The Interest Expense is 3.17% of Operating Income.
  • The Net Earning history of RDY is 18.33% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 13 years.

Dr Reddy's Laboratories Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: RDY
CUSIP: 256135
Website: drreddys.com

Debt

Debt-to-Equity Ratio: 0.06
Current Ratio: 2.55
Quick Ratio: 1.8

Price-to-Earnings

Trailing P/E Ratio: 22.07
Forward P/E Ratio: 21.07

RDY Technical Analysis vs Fundamental Analysis

Sell
45
Dr Reddy's Laboratories (RDY) is a Sell

Is Dr Reddy's Laboratories a Buy or a Sell?